Clinical Trial Update: Apatinib Combined With S-1 for the Treatment of Recurrent/Metastatic Head and Neck Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update investigating the combination of apatinib and S-1 for recurrent/metastatic head and neck cancers (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Apatinib (apatinib)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: China International Medical Foundation | Conditions: Head and Neck Cancer | Phase 1, Phase 2 | Status: UNKNOWN